Neuromodulation a Method to Treat Constant Migraine - or is it just more hype?

Neuromodulation method for healing constant and severe migraine was quiet beneficial, claimed a study published in the St Jude Medical journal. The company had done an experiment in which the origins of neurostimulator was used to deliver peripheral stimulation of the occipital nerve to 157 participants suffering from headaches 26 days per month on an average.

The results of the experiment revealed that the occurrence of headaches and inabilities had reduced to a great extent which was further compared to the data of the group of patients with controlled migraine problem.

The St Jude Medical was waiting for authoritization from the European Union for the Genesis as a process of healing the constant migraine suffering of the people and wanted to launch the product as soon as possible in Europe. Previous month the company came up with a Pressure Wire device which was cost-effective and beneficial in treating the heart-borne diseases.

http://topnews.net.nz/content/216277-neuromodulation-method-treat-constant-migraine
____________________________________________________________________________________________________________

Nerve-Stimulating Migraine Implants Still More Hype than Hope
POSTED BY: ERICA WESTLY / WED, JUNE 29, 2011


About 10 percent of the world's population suffers from migraines, according to a recent WHO report. Patients have a number of symptom-relieving medications to choose from, but drug companies have yet to develop a surefire treatment, leaving the door open for alternatives, such as electrical nerve stimulation and even Botox.

Much of the research in the nerve stimulation category has focused on the occipital nerve, a spinal nerve that extends over much of the back of the head. Studies going back to the 1970s have suggested that stimulating the occipital nerve could help to prevent migraines, but, so far, attempts to turn this research into a medical device have been somewhat disappointing.

Last fall, Minneapolis-based Medtronic published results from a preliminary clinical study of its adjustable occipital nerve implant. For about 40 percent of patients, the device reduced migraine frequency by half—enough to merit further study but nothing to write home about, especially when you consider that 24 percent of patients had problems with lead migration and 14 percent of patients got infections at the site of the implants.

Last week, St. Jude Medical, also based in Minnesota, announced results from a study of its occipital nerve implant. The study found that 66 percent of patients who received the implant reported "good pain relief" after a year, which sounds good until you learn that the placebo treatment—device without electric stimulation—yielded similar results. St. Jude's implant did succeed in significantly reducing migraine frequency: Patients reported a reduction of about seven days a month, equivalent to a 28 percent decrease. Still, an industry analyst declared the study a failure and said FDA approval was unlikely at this point.

http://spectrum.ieee.org/tech-talk/biomedical/devices/nerve-stimulating-migraine-implants

Neuromodulation already exists in the form of the use of anti/c's and some anti/d's to try and prevent migarine.
Not sure what they are proposing is new.